Bullock TN - Search Results

1

Stimulating CD27 to quantitatively and qualitatively shape adaptive immunity to cancer.

Bullock TN. Bullock TN. Curr Opin Immunol. 2017 Apr;45:82-88. doi: 10.1016/j.coi.2017.02.001. Epub 2017 Mar 17. Curr Opin Immunol. 2017. PMID: 28319731 Free PMC article. Review.

2

Immunity to melanoma antigens: from self-tolerance to immunotherapy.

Slingluff CL Jr, Chianese-Bullock KA, Bullock TN, Grosh WW, Mullins DW, Nichols L, Olson W, Petroni G, Smolkin M, Engelhard VH. Slingluff CL Jr, et al. Among authors: bullock tn. Adv Immunol. 2006;90:243-95. doi: 10.1016/S0065-2776(06)90007-8. Adv Immunol. 2006. PMID: 16730266 Review.

3

Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cells.

Roberts DJ, Franklin NA, Kingeter LM, Yagita H, Tutt AL, Glennie MJ, Bullock TN. Roberts DJ, et al. Among authors: bullock tn. J Immunother. 2010 Oct;33(8):769-79. doi: 10.1097/CJI.0b013e3181ee238f. J Immunother. 2010. PMID: 20842060 Free PMC article.

4

CD27 stimulation promotes the frequency of IL-7 receptor-expressing memory precursors and prevents IL-12-mediated loss of CD8(+) T cell memory in the absence of CD4(+) T cell help.

Dong H, Franklin NA, Roberts DJ, Yagita H, Glennie MJ, Bullock TN. Dong H, et al. Among authors: bullock tn. J Immunol. 2012 Apr 15;188(8):3829-38. doi: 10.4049/jimmunol.1103329. Epub 2012 Mar 14. J Immunol. 2012. PMID: 22422886 Free PMC article.

5

Acute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.

Teoh JJ, Gamache AE, Gillespie AL, Stadnisky MD, Yagita H, Bullock TN, Brown MG. Teoh JJ, et al. Among authors: bullock tn. J Immunol. 2016 Dec 1;197(11):4360-4370. doi: 10.4049/jimmunol.1601049. Epub 2016 Oct 24. J Immunol. 2016. PMID: 27798162 Free PMC article.

6

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors.

Burris HA, Infante JR, Ansell SM, Nemunaitis JJ, Weiss GR, Villalobos VM, Sikic BI, Taylor MH, Northfelt DW, Carson WE 3rd, Hawthorne TR, Davis TA, Yellin MJ, Keler T, Bullock T. Burris HA, et al. J Clin Oncol. 2017 Jun 20;35(18):2028-2036. doi: 10.1200/JCO.2016.70.1508. Epub 2017 May 2. J Clin Oncol. 2017. PMID: 28463630 Clinical Trial.

7

TNF-receptor superfamily agonists as molecular adjuvants for cancer vaccines.

Bullock TN. Bullock TN. Curr Opin Immunol. 2017 Aug;47:70-77. doi: 10.1016/j.coi.2017.07.005. Epub 2017 Jul 24. Curr Opin Immunol. 2017. PMID: 28750279 Free PMC article. Review.

8

Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?

Obeid JM, Kunk PR, Zaydfudim VM, Bullock TN, Slingluff CL Jr, Rahma OE. Obeid JM, et al. Among authors: bullock tn. Cancer Immunol Immunother. 2018 Feb;67(2):161-174. doi: 10.1007/s00262-017-2082-z. Epub 2017 Oct 20. Cancer Immunol Immunother. 2018. PMID: 29052780 Free PMC article. Review.

9

Deciphering T Cell Immunometabolism with Activity-Based Protein Profiling.

Borne AL, Huang T, McCloud RL, Pachaiyappan B, Bullock TNJ, Hsu KL. Borne AL, et al. Curr Top Microbiol Immunol. 2019;420:175-210. doi: 10.1007/82_2018_124. Curr Top Microbiol Immunol. 2019. PMID: 30128827 Free PMC article. Review.

10

Frontline Science: Late CD27 stimulation promotes IL-7Rα transcriptional re-expression and memory T cell qualities in effector CD8⁺ T cells.

Dong H, Buckner A, Prince J, Bullock T. Dong H, et al. J Leukoc Biol. 2019 Nov;106(5):1007-1019. doi: 10.1002/JLB.1HI0219-064R. Epub 2019 Jun 14. J Leukoc Biol. 2019. PMID: 31199542 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters